Concepedia

Paromita Raha

PR

8

Publications

688

Citations

8

H-Index

2011

Active since

Affiliations

University of California, San Francisco(Current)

Paromita Raha is an author at University of California, San Francisco specializing in oncology, radiation oncology, and medicine.

ORCID

Top concepts

Publications per year

2011–2022

8

Publications

8

A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer

Pamela N. Münster, Kenneth T. Thurn, Scott Thomas et al. · British Journal of Cancer · 2011 · 386 citations · Full text

Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling

Kenneth T. Thurn, Scott Thomas, Paromita Raha et al. · Molecular Cancer Therapeutics · 2013 · 108 citations · Full text

Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression

Paromita Raha, Scott Thomas, Kenneth T. Thurn et al. · Breast Cancer Research · 2015 · 91 citations · Full text

A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma

Scott Thomas, Rahul Aggarwal, Thierry Jahan et al. · Annals of Oncology · 2016 · 31 citations · Full text

, , +6

Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt

Scott Thomas, Kenneth T. Thurn, Paromita Raha et al. · PLoS ONE · 2013 · 30 citations · Full text

, , +16

Rows per page

1–5 of 8